• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avalyn Pharma Inc. - common stock (NQ:AVLN)

27.06 +0.07 (+0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 327,007
Open 27.19
Bid (Size) 25.50 (200)
Ask (Size) 29.80 (200)
Prev. Close 26.99
Today's Range 25.77 - 29.51
52wk Range 24.15 - 32.23
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead ↗
June 05, 2026
Avalyn Pharma (NASDAQ:AVLN) executives outlined the company’s inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies... 
Via MarketBeat
Topics Initial Public Offering
News headline image
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
June 03, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire

Performance

YTD
-8.2%
-8.2%
1 Month
-2.3%
-2.3%
3 Month
-8.2%
-8.2%
6 Month
-8.2%
-8.2%
1 Year
-8.2%
-8.2%

More News

Read More
News headline image
Avalyn to Participate in the Jefferies Global Healthcare Conference
May 27, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026
May 21, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
May 05, 2026
From Avalyn Pharma Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Avalyn Pharma Inc. - common stock publicly traded?
Yes, Avalyn Pharma Inc. - common stock is publicly traded.
What exchange does Avalyn Pharma Inc. - common stock trade on?
Avalyn Pharma Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avalyn Pharma Inc. - common stock?
The ticker symbol for Avalyn Pharma Inc. - common stock is AVLN on the Nasdaq Stock Market
What is the current price of Avalyn Pharma Inc. - common stock?
The current price of Avalyn Pharma Inc. - common stock is 27.06
When was Avalyn Pharma Inc. - common stock last traded?
The last trade of Avalyn Pharma Inc. - common stock was at 06/05/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap